You may have to register before you can download all our books and magazines, click the sign up button below to create a free account.
This volume an overview of current research in the field of immunology as it relates to diabetes. Topics covered include: autoantibody markers for type 1 diabetes; cellular immune markers for type 1 diabetes; animal models of type 1 diabetes; the pancreas in type 1 diabetes; genetics of type 1 diabetes; the role of toll-like receptors and innate immunity in type 1 diabetes; cell-based therapies for type 1 diabetes; environmental and mechanistic causes of type 1 diabetes; mechanisms of beta-cell death; role of the immune response in type 1 diabetes; and islet transplantation. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.
description not available right now.
Volume I.C An outbreak of a respiratory disease first reported in Wuhan, China in December 2019 and the causative agent was discovered in January 2020 to be a novel betacoronovirus of the same subgenus as SARS-CoV and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) has rapidly disseminated worldwide, with clinical manifestations ranging from mild respiratory symptoms to severe pneumonia and a fatality rate estimated around 2%. Person to person transmission is occurring both in the community and healthcare settings. The World Health Organization (WHO) has recently declared the COVID-19 epidemic a public health emergency of international ...
Schätzungen zufolge lebt etwa einer von zehn Erwachsenen mit Diabetes – die meisten davon mit Typ-2-Diabetes, der tendenziell später einsetzenden Form der Stoffwechselstörung. Die Zuckerkrankheit schränkt die Lebensqualität vieler Betroffener ein, zudem erhöht sie das Risiko für zusätzliche schwere Erkrankungen. Doch wie entsteht sie eigentlich? Könnte man Fälle verhindern, zum Beispiel mit einer Impfung? Welche anderen Maßnahmen zur Vorsorge gibt es? Und sind neue Behandlungsoptionen am Horizont? Antworten auf diese Fragen finden Sie in diesem Kompakt